Eam Investors, LLC Codexis, Inc. Transaction History

Eam Investors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$2.59 - $4.65 $516,637 - $927,554	199,474 New	199,474 $696,000
Q1 2022 May 13, 2022	SELL	$16.97 - $31.93 $551,321 - $1.04 Million	-32,488 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$25.61 - $41.78 $832,017 - $1.36 Million	32,488 New	32,488 $1.02 Million
Q3 2019 Nov 13, 2019	SELL	$12.75 - $19.01 $789,747 - $1.18 Million	-61,941 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$17.0 - $21.88 $2.33 Million - $3.01 Million	-137,346 Reduced 68.92%	61,941 $1.14 Million
Q1 2019 May 13, 2019	SELL	$15.53 - $22.15 $516,791 - $737,085	-33,277 Reduced 14.31%	199,287 $4.09 Million
Q4 2018 Feb 13, 2019	BUY	$14.06 - $22.57 $1.23 Million - $1.97 Million	87,465 Added 60.28%	232,564 $3.88 Million
Q3 2018 Nov 08, 2018	SELL	$13.35 - $19.1 $148,532 - $212,506	-11,126 Reduced 7.12%	145,099 $2.49 Million
Q2 2018 Aug 03, 2018	SELL	$10.35 - $16.45 $103,986 - $165,273	-10,047 Reduced 6.04%	156,225 $2.25 Million
Q1 2018 May 14, 2018	BUY	$8.0 - $12.8 $631,976 - $1.01 Million	78,997 Added 90.52%	166,272 $1.83 Million
Q4 2017 Feb 12, 2018	BUY	$5.85 - $8.4 $510,558 - $733,110	87,275	87,275 $729,000

125

59.9M

25.9K

20.1K

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $335M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.